Table 2.
Examples of miRNAs reported more consistently to be expressed differentially in prostate adenocarcinomas
| MiRNA | References to consistent reports of down-regulation of miRNA in prostate adenocarcinomas (fold change if specified) | References to consistent reports of up-regulation of miRNA in prostate adenocarcinomas (fold change if specified) |
|---|---|---|
| miRNA-20a | Szczyrba et al. 2010 (1.5) | |
| Volinia et al. 2005 | ||
| miRNA-23b | Tong et al. 2008 (−1.2) | |
| Porkka et al. 2007 1 | ||
| miRNA-25 | Szczyrba et al. 2010 (1.8) | |
| Volinia et al. 2006 | ||
| Ambs et al. 2008 | ||
| miRNA-26a | Carlsson et al. 2011 | |
| Porkka et al. 2007 | ||
| miRNA-27b | Carlsson et al. 2011 | |
| Szczyrba et al. 2010 | ||
| Porkka et al. 2007 1 | ||
| miRNA-29a | Volinia et al. 2005 | |
| Porkka et al. 2007 1 | ||
| Szczyrba et al. 2010 (−2.4) | ||
| Ru et al. 2012 | ||
| Porkka et al. 2007 1 | ||
| Steele et al. 2010 | ||
| miRNA-32 | Volinia et al. 2006 | |
| Ambs et al. 2008 | ||
| miRNA-100 | Tong et al. 2008 (−1.2) | |
| Porkka et al. 2007 1 | ||
| miRNA-106a | Szczyrba et al. 2010 (2.8) | |
| Volinia et al. 2006 | ||
| miRNA-106b | Szczyrba et al. 2010 (2.3) | |
| miRNA-143 | Szczyrba et al. 2010 (−4) | |
| Porkka et al. 2007 | ||
| Carlsson et al. 2011 | ||
| Tong et al. 2008 (−1.3) | ||
| miRNA-145 | Zaman et al. 2010 | |
| Porrka et al. 2007 | ||
| Ozen et al. 2008 | ||
| miRNA-205 | Hulf et al. 2012 | |
| Porkka et al. 2007 1 | ||
| miRNA-221 | Tong et al. 2008 (−1.3) | |
| Porkka et al. 2007 | ||
| miRNA-222 | Tong et al. 2008 (−1.5) | |
| Porkka et al. 2007 |
1
Only in hormone resistant cases.